TNXP
Tonix Pharmaceuticals Holding Corp.
NASDAQ · USHealthcareBiotechnology
$10.98-11.67%
Price as of Jul 20, 2026
TNXP capital
Tonix Pharmaceuticals Holding Corp. capital & dividend
Leverage, liquidity, debt coverage and shareholder-distribution metrics.
Leverage
- Debt / equity
- 0.01x
- Net debt / equity
- -0.81x
- Debt / assets
- 0.01x
- Debt / EBITDA
- -0.01x
- Net debt / EBITDA
- 1.27x
Liquidity & coverage
- Current ratio
- 6.99x
- Quick ratio
- 6.86x
- Cash ratio
- 6.26x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $177.5M
Cash & dividend
- FCF / debt
- -102.83x
- Cash flow / debt
- -97.35x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.